Relmada Therapeutics Inc (NASDAQ:RLMD) price on Wednesday, May 21, fall -13.02% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.52.
A look at the stock’s price movement, the close in the last trading session was $0.60, moving within a range at $0.49 and $0.6591. The beta value (5-Year monthly) was 0.181. Turning to its 52-week performance, $4.47 and $0.24 were the 52-week high and 52-week low respectively. Overall, RLMD moved 37.38% over the past month.
Relmada Therapeutics Inc’s market cap currently stands at around $17.24 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-11.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RLMD is a 50% Buy. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 0 recommend RLMD as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Sell which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
RLMD’s current price about 20.13% and 45.68% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 58.58, while 7-day volatility ratio is 22.61% and 27.70% in the 30-day chart. Further, Relmada Therapeutics Inc (RLMD) has a beta value of 0.50, and an average true range (ATR) of 0.08. Analysts have given the company’s stock an average 52-week price target of $7, forecast between a low of $2 and high of $8. Looking at the price targets, the low is -284.62% off current price level while to achieve the yearly target high, price needs to move -1438.46%. Nonetheless, investors will most likely welcome a -1246.15% jump to $7 which is the analysts’ median price.
If we refocus on Relmada Therapeutics Inc (NASDAQ:RLMD), historical trading data shows that trading volumes averaged 0.97 over the past 10 days and 1.74 million over the past 3 months. The company’s latest data on shares outstanding shows there are 33.19 million shares.
The 16.22% of Relmada Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 25.06% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.03 million on 2025-04-30, giving us a short ratio of 0.53. The data shows that as of 2025-04-30 short interest in Relmada Therapeutics Inc (RLMD) stood at 627.0 of shares outstanding, with shares short rising to 1.62 million registered in 2025-03-31. Current price change has pushed the stock -0.13% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RLMD stock continues to rise going into the next quarter.
